Skip to main content

Peer Review reports

From: Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers

Original Submission
8 Apr 2013 Submitted Original manuscript
1 Jun 2013 Reviewed Reviewer Report - Luigi Uccioli
27 Jun 2013 Reviewed Reviewer Report - Carlo Maria Ferdinando Caravaggi
28 Jun 2013 Author responded Author comments - Isis B. Yera-Alos
Resubmission - Version 2
28 Jun 2013 Submitted Manuscript version 2
23 Jul 2013 Reviewed Reviewer Report - Luigi Uccioli
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
30 Jul 2013 Editorially accepted
3 Sep 2013 Article published 10.1186/2050-6511-14-44

You can find further information about peer review here.

Back to article page